London-based Perci Health Secures €4 Million to Expand AI-Driven Virtual Cancer Clinic
Jun 12, 2025 | By Kailee Rainse

UK-based HealthTech scale-up Perci Health, which runs a comprehensive virtual cancer clinic, has raised €4 million in its latest funding round—double its original €2 million target. This brings the company’s total funding to €10.4 million.
SUMMARY
- UK-based HealthTech scale-up Perci Health, which runs a comprehensive virtual cancer clinic, has raised €4 million in its latest funding round—double its original €2 million target. This brings the company’s total funding to €10.4 million.
The round includes a €399k investment from Macmillan Cancer Support. New investors Guinness Ventures and Conduit Fund joined existing backers Octopus Ventures and 35 leading oncologists and cancer surgeons in supporting Perci Health’s mission.
“Our mission to close the cancer care gap is powered by an outstanding team who are deeply committed to transforming the cancer care experience,” said Kelly McCabe, Co-Founder and CEO of Perci Health. “This investment will allow us to continue pioneering a model of care that integrates digital innovation with compassionate, specialist-led support, providing better outcomes for everyone living with and beyond cancer.”
McCabe, Co-founder and CEO, is a specialist oncology dietitian with experience in NHS hospital management and as former COO of a private cancer care network. Fitzsimons, Co-founder and Chief Customer Officer, brings expertise in digital transformation and consumer experience, having held senior roles at CBS Television and ASOS.
RECOMMENDED FOR YOU

[Funding alert] German Deeptech firm Orbem Secures €30M Series A Funding
Team SR
Oct 11, 2023

doinstruct funding news – Germany-based doinstruct Secures €7.6Million in Funding
Team SR
Jul 16, 2024
Read Also - French Robotics Firm Wandercraft Raises €64.3 Million In Series D Round
The latest funding will help Perci Health expand its AI-powered, multidisciplinary virtual cancer clinic to reach more patients and healthcare providers across the UK.
With a network of over 85 NHS-trained specialists, the platform offers highly personalised and flexible care, empowering patients to take control of their condition and quality of life. Perci Health combines digital innovation with human expertise to provide meaningful ongoing support.
“We’re incredibly impressed by the way Perci Health is tackling the gaps in cancer care with a human-first, tech-enabled model,” said Chantal Cox , Investor at Octopus Ventures. “This approach not only addresses pressing healthcare needs but also delivers measurable impact in terms of both clinical outcomes and cost-efficiency, which is vital for scaling the model across more insurers, employers, and health systems.”
Perci Health is one of the few UK scale-ups founded by an all-female team. Women make up 100% of its directors, 80% of its leadership team, and 60% of its executive board. Despite the fact that less than 2% of venture capital typically goes to female-led teams (as noted by the company), Perci Health has managed to raise twice the average deal size for UK female-led startups in each of its funding rounds.
“Supporting businesses that are developing scalable, meaningful impact in healthcare is a priority for us,” said Eva-Maria Dimitriadis, Managing Partner at Conduit Fund. “Perci Health’s innovative, patient-centric model, combined with its strong leadership and growth potential, is precisely the kind of forward-thinking solution that we want to help grow. As a female led business ourselves – with a majority female investment team – we know female Founders statistically find it considerably more difficult to raise from VCs. We believe investing in female Founders is not just the right thing to do, but it gives us access to exceptional opportunities that others overlook. 42% of companies we have invested in have at least one female Founder and we are thrilled to add Perci Health to that list.”
According to Macmillan, nearly 3.5 million people in the UK are currently living with cancer—a number that is expected to keep growing. This highlights the urgent need for new and effective ways to support patients.
Perci Health points out that the UK’s cancer outcomes are up to 25 years behind those of other European countries. In England, 41% of staged cancer diagnoses are made at a late stage, and around a third of eligible individuals miss important screening appointments for breast, bowel, and cervical cancers.
“Cancer survivorship presents unique challenges, and we must innovate to meet the growing needs of people living with and beyond cancer,” added Claire Taylor, Chief Nursing Officer, Macmillan Cancer Support. “Perci Health’s holistic, multidisciplinary approach is exactly the exciting innovation that is needed, and it aligns perfectly with Macmillan’s ambitions to help more people get the personalised care they need. This partnership represents a shared commitment to making a real difference in the lives of those affected by cancer, helping people to live well and by providing tailored solutions to meet their changing needs following a cancer experience.”
Improving cancer outcomes in the UK will require joint efforts from the government, NHS, private insurers, charities, and employers. Perci Health’s model is designed to help bridge these gaps by providing end-to-end care—from prevention and early detection to treatment support, symptom management, and survivorship care.
“We know that cancer doesn’t stop when treatment ends. In fact, that’s often when people need the most support. Perci Health’s AI-driven platform ensures truly personalised care, enabling people to access the right support at the right time,” said Morgan Fitzsimons, Co-Founder and Chief Customer Officer.
This investment comes at a time when the UK government is placing greater focus on vocational rehabilitation and reducing long-term sickness absence, as outlined in the “Keep Britain Working Review.” Perci Health supports these goals by offering earlier intervention, personalised recovery plans, and return-to-work programmes that tackle both physical and mental health challenges.
“At Guinness Ventures, we look for Founders who are solving meaningful problems in an innovative way,” said Lisa Fox, Head of Co-Investment, Guinness Ventures. “Perci Health is doing exactly that in addressing one of the biggest and most underserved challenges in cancer care: how we support people after treatment ends. Their model combines clinical rigour with scalable technology, delivering meaningful outcomes not just for patients, but also for employers, insurers, and the broader healthcare ecosystem.”
“With more people living with cancer, there’s an urgent need for healthcare solutions that cater to long-term survivorship.By working with insurers, employers and healthcare providers, we aim to reshape cancer care to ensure better outcomes for patients and cost savings for the system, ” said McCabe.
About Perci Health
Founded in 2020 by healthcare innovators Kelly McCabe and Morgan Fitzsimons, Perci Health is on a mission to transform how cancer is managed—from prevention to treatment and recovery.
Recommended Stories for You

AnaCardio funding news – AnaCardio has Raised €17.8 Million in a Series A Extension Round Funding
Kailee Rainse Jan 10, 2025